Vasorum was co-founded by Dr. James Coleman, who has extensive experience in the medical device industry and in particular in the development of vascular closure devices. The Company is located in Dublin, Ireland.
Vasorum has received PMA approval and CE Mark for the Celt ACD®, which allows rapid closure of an arterial puncture site after percutaneous catheter-based vascular procedures. The Celt ACD is available in three sizes to fit 5F, 6F and 7F sheaths and does not require exchange of the existing procedural sheath before deployment. With more than 60,000 patients implanted to date, Celt ACD has proven itself to be a best in class vascular puncture closure device.
We are delighted to have secured this investment. BGF shares our vision for growing this business over the coming years and will assist us to realise our ambitions. Vasorum will use this investment to accelerate adoption of the CELT ACD in the US market, and to broaden our product offering. I would like to thank our staff and existing shareholders, including Enterprise Ireland, for their hard work and support to date, and I look forward to a bright future as we enter the next phase of development.Dr. Jim Coleman, CEO
Business funding insights
BGF explains: initial public offerings (IPOs)
We explain what’s meant by an initial public offering (IPO), also known as listing or ‘going public’.
When to pursue debt refinancing and why
You may find that refinancing or renegotiating your business debts can put you in a stronger financial position. Look at…